| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Nonalcoholic Steatohepatitis |
0 |
0.99 |
| Biliary Disease |
0 |
0.7 |
| Alcoholism |
0 |
0.63 |
| Addiction |
0 |
0.54 |
| Hypertension |
0 |
0.53 |
| Aminotransferase |
0 |
0.52 |
| Liver |
0 |
0.38 |
| Hepatic Fibrosis |
0 |
0.35 |
| Platelet Count |
0 |
0.34 |
| Cardiometabolic Risk Factors |
0 |
0.31 |
| Portal Hypertension |
0 |
0.25 |
| Alcohol Abuse |
0 |
0.18 |
| Abuse |
0 |
0.13 |
| Biopsy |
0 |
0.13 |
| Blood |
0 |
0.13 |
| Food and Drug Administration (FDA) |
0 |
0.13 |
| Heart |
0 |
0.13 |
| Hospital |
0 |
0.13 |
| Injury |
0 |
0.13 |
| Kidney |
0 |
0.13 |
| Lung |
0 |
0.13 |
| Metabolism |
0 |
0.13 |
| Preventive Screening |
0 |
0.13 |
| Texas |
0 |
0.13 |
| Transplant Evaluation |
0 |
0.13 |
| Wound Management |
0 |
0.13 |